Colon cancer cell biology: splicing, signaling and beyond

Jordan, Peter

http://hdl.handle.net/10400.18/6843

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
CEDOC seminar_Mar 2019.pdf		4.62 MB	Adobe PDF	Download

Send Feedback

Authors

Jordan, Peter

Abstract(s)

Introduction: In colon cancer distinct genetic subtypes have been described, one of which involves overexpression of RAC1b, a variant generated by alternative splicing. Aberrant splicing is known to occur in cancer and can be caused by mutation in a gene or splicing factor but also represents a dynamic response to oncogene-induced cellular signaling and in this case it may be pharmacologically targeted. Here we explore how signaling pathways are involved in the deregulation of alternative RAC1b splicing in colorectal tumor cells.